Expression of interleukin 6 in synovial tissues in patients with internal derangement of the temporomandibular joint

British Journal of Oral and Maxillofacial Surgery

Volumn 41, Issue 2, 2003, Pages 95-101

  Sato, Jun ^a   Segami, N ^a   Nishimura, M ^a   Demura, N ^a   Yoshimura, H ^a   Yoshitake, Y ^a   Nishikawa, K ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETODOLAC; INTERLEUKIN 6; LOXOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTHROSCOPIC SURGERY; ARTICLE; BLOOD VESSEL; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT EFFUSION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; RECURRENT DISLOCATION; SYNOVIOCYTE; SYNOVIUM; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 0038066852     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0266-4356(02)00294-2     Document Type: Article

References (26)

1. Fu K, Ma X, Zhang Z, Pang X, Chen W. Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain 1995; 9: 131-137.
2. Fu K, Ma X, Zhang Z, Chen W. Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 1995; 53: 424-426.
3. Kubota E, Kubota T, Matsumoto J, Shibata T, Murakami K. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 1998; 56: 192-198.
4. Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 135-141.
5. Kopp S. The influence of neuropeptides, serotonin, and interleukin 1β on temporomandibular joint pain and inflammation. J Oral Maxillofac Surg 1998; 56: 189-191.
6. Suzuki T, Segami N, Kaneyama K, Nishimura M, Nojima T. Specific expression of interleukin 1β in temporomandibular joints with internal derangement: correlation with clinical findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 413-417.
7. Henry CH, Wolford LM. Substance P and mast cells: preliminary histologic analysis of the human temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 384-389.
8. Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M. Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 2002; 40: 68-71.
9. Segami N, Miyamaru M, Nishimura M, Suzuki T, Kaneyama K, Murakami K. Does joint effusion on T2 MRI reflect synovitis? Part 2. Comparison with concentration levels of proinflammatory cytokines and protein in synovial fluid of the temporomandibular joint with internal derangements. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 515-521.
10. Segami N, Kaneyama K, Tsurusako S, Suzuki T. Arthroscopic eminoplasty for habitual dislocation of the temporomandibular joint: preliminary study. J Craniomaxillofac Surg 1999; 27: 390-397.
11. Sato J, Segami N, Suzuki T, Kaneyama K, Yoshitake Y, Nishikawa K. The expression of vascular endothelial growth factor in synovial tissues in patients with internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 251-256.
12. Sato J, Segami N, Nishimura M, Kaneyama K, Demura N, Yoshimura H. Relation between the expression of vascular endothelial growth factor in synovial tissues and the extent of joint effusion seen on magnetic resonance imaging in patients with internal derangement of the temporomandibular joint. Br J Oral Maxillofac Surg (this issue).
13. McCain JP, de la Rua H, LeBlanc WG. Puncture technique and portals of entry for diagnostic and operative arthroscopy of the temporomandibular joint. Arthroscopy 1991; 7: 221-232.
14. Murakami K, Segami N, Fujimura K, Iizuka T. Correlation between pain and synovitis in patients with internal derangement of the temporomandibular joint. J Oral Maxillofac Surg 1991; 49: 1159-1161.
15. Segami N, Nishimura M, Kaneyama K, Miyamaru M, Sato J, Murakami K. Does joint effusion on T2 magnetic resonance images reflect synovitis? Comparison of arthroscopic findings in internal derangements of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 341-345.
16. Westesson PL, Brooks SL. Temporomandibular joint: relationship between MR evidence of effusion and the presence of pain and disc displacement. AJR 1992; 159: 559-563.
17. Murakami K, Nishida M, Bessho K, Iizuka T, Tsuda Y, Konishi J. MRI evidence of high signal intensity and temporomandibular arthralgia and relating pain. Does the high signal correlate to the pain? Br J Oral Maxillofac Surg 1996; 34: 220-224.
18. Sandler NA, Buckely M, Cillo JE, Braun TW Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint. J Oral Maxillofac Surg 1998; 56: 534-543.
19. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993; 54: 1-78.
20. Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis 2000; 59 (Suppl 1): i21-i27.
21. Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg 2002; 40: 418-423.
22. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M. Synovium as a source of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 1989; 83: 585-592.
23. Jorgensen C, Apparailly F, Sany J. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt? Ann Rheum Dis 1999; 58: 136-141.
24. Sacerdote P, Carrabba M, Galante A, Pisati R, Manfredi B, Panerai AE. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen. Inflamm Res 1995; 44: 486-490.
25. Wendling D, Racadot E, Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J Rheumatol 1993; 20: 259-262.
26. Elliott M, Maini RN, Feldmann M et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344: 1105-1110.